Sacubitril/Valsartan Sodium Hydrate | Interleukin Related interleukin-related.com

Product Name :
Sacubitril/Valsartan Sodium Hydrate

Search keywords :
CD10

drugId :
null

Target Vo:
Angiotensin II Receptor Type 1

Target Vo Short Name :
AT1

Moa_Name:
Neprilysin inhibitors

First Approval Country :
United States

First Approval Date Filter:
2015

Origin Company_Name :
Novartis Pharma Ag

Active Company_Name :
Azienda Ospedaliero Universitaria Careggi

Active Indication_Name:
Heart Failure

In Active Indication_Name:
Hepatic Insufficiency

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD74 Antibody (YA1282) Technical Information
Mirikizumab Autophagy
BRG1 Antibody: BRG1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 185 kDa, targeting to BRG1. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts